News

Video

Inmar & Premier's Anticipated Impact on The Broader Pharmacy and Healthcare Ecosystem

Rob DeWig, Vice President of Healthcare Sales, Inmar, touches on the impact of Inmar and Premier's expanded agreement on the broader healthcare and pharmacy ecosystems.

Pharmaceutical Executive: What impact do you anticipate for the broader pharmacy and healthcare ecosystem due to Inmar’s expanded agreement with Premier?
Rob DeWig: So one thing we've been focused on the strategy here at Inmar is bringing more solutions. So, you know, Premier hospitals or Premier members have a single point for multiple solutions that we can help solve that are critical to their operating today, and so, you know, at the beginning it was just reverse distribution, just handling of unsaleable returns and making sure that we're getting credit back. And it's really grown to multiple solutions. So now on Premier agreements, we have now a dscsa, the revenue cycle management, but we have a recall management tool, as well as some workflow optimization tools around tray automation and delivering meds, patient specific meds. So it's really trying to and said, You know, I once heard a podcast interview with from major health system. He said, I have 160 different systems running in my pharmacy. You know, if you can reduce that down to a single vendor, vendor handles multiple solutions, it makes a lot easier to manage from their point of view, instead of having to track down who do I need to contact if there are issues or I need to expand on a service. And so I think our partnership with Premier has been many years in the making, and we're just excited to that they see the value that we bring to their members, and they're they wanted to not only renew a contract, but also expand our services into revenue cycle management.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Videos
Ryan Quigely
Pharmaceutical Executive
Pharmaceutical Executive
© 2025 MJH Life Sciences

All rights reserved.